Showing results (1011-1020 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|December 15, 2022
Peri-procedural management of transcatheter mitral valve replacement in patients with heart failureSara L Hungerford, Gry Dahle, Alison Duncan, et al.European Journal of Heart Failure|January 4, 2023
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosisGiuseppe Vergaro, Vincenzo Castiglione, Alberto Aimo, et al.European Journal of Heart Failure|June 15, 2022
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trialMasatake Kobayashi, Nicolas Girerd, João Pedro Ferreira, et al.European Journal of Heart Failure|June 17, 2022
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-ReducedFaiez Zannad, João Pedro Ferreira, John Gregson, et al.European Journal of Heart Failure|June 1, 2022
Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitationChristos Iliadis, Daniel Kalbacher, Philipp Lurz, et al.European Journal of Heart Failure|June 23, 2022
Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristicsWilfried Mullens, Jeroen Dauw, Pieter Martens, et al.European Journal of Heart Failure|July 5, 2022
BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelinesMichele Massimo Gulizia, Francesco Orso, Andrea Mortara, et al.European Journal of Heart Failure|July 1, 2022
Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of CardiologyMarco Guazzi, Matthias Wilhelm, Martin Halle, et al.European Journal of Heart Failure|May 5, 2022
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studiesAlberto Aimo, Marco Merlo, Aldostefano Porcari, et al.European Journal of Heart Failure|May 28, 2019
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real worldChris J Kapelios, Mitja Lainscak, Gianluigi Savarese, et al.Pageof 398